Question 1

Does Ubs own ALGS stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Ubs holds 59,986 shares of ALGS (Aligos Therapeutics), worth $346,119.

Question 2

How many shares of ALGS does Ubs own?

Accepted Answer

As of its Q2 2026 13F, Ubs holds 59,986 shares of ALGS (Aligos Therapeutics).

Question 3

What is Ubs' ALGS position worth?

Accepted Answer

As of its Q2 2026 13F, Ubs' ALGS position is worth $346,119.

Question 4

Is Ubs buying or selling ALGS?

Accepted Answer

In Q2 2026, Ubs increased its ALGS position by 22,925 shares (+61.9%).

Question 5

When did Ubs first buy ALGS?

Accepted Answer

Ubs first reported ALGS in its Q3 2024 13F and has listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	59,986	+61.9%	$346,119	0.0%	$5.77	23
2026-Q1	Increased	37,061	+101x	$275,363	0.0%	$6.85	26
2025-Q4	Decreased	364	-97.8%	$3,392	0.0%	$9.12	0
2025-Q3	Increased	16,182	+489.9%	$158,584	0.0%	$9.62	25
2025-Q2	Decreased	2,743	-67.6%	$19,777	0.0%	$7.21	0
2025-Q1	Decreased	8,461	-45.5%	$69,803	0.0%	$9.12	0
2024-Q4	Increased	15,521	+1108x	$618,358	0.0%	$40.47	39
2024-Q3	New	14	-	$121	0.0%	$8.04	17

ALGS8 quarters

ALGS
8 quarters